Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug interaction studies with remoxipride.

W Yisak1, C von Bahr, L Farde

  • 1Astra Research Centre, Södertälje, Sweden.

Acta Psychiatrica Scandinavica. Supplementum
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Altered Serotonin 1B Receptor Binding After Escitalopram for Depression Is Correlated With Treatment Effect.

The international journal of neuropsychopharmacology·2024
Same author

Disease activity in rheumatoid arthritis is inversely related to cerebral TSPO binding assessed by [<sup>11</sup>C]PBR28 positron emission tomography.

Journal of neuroimmunology·2019
Same author

Increased number of monocytes and plasma levels of MCP-1 and YKL-40 in first-episode psychosis.

Acta psychiatrica Scandinavica·2018
Same author

Association between body mass index and sperm quality and sperm DNA integrity. A large population study.

Andrologia·2017
Same author

Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [<sup>11</sup>C]PBR28.

Molecular psychiatry·2017
Same author

Mapping the distribution of serotonin transporter in the human brainstem with high-resolution PET: Validation using postmortem autoradiography data.

NeuroImage·2016
Same journal

Use of psychotropic drugs during pregnancy and breast-feeding.

Acta psychiatrica Scandinavica. Supplementum·2015
Same journal

Getting depression clinical practice guidelines right: time for change?

Acta psychiatrica Scandinavica. Supplementum·2013
Same journal

Manipulating melatonin in managing mood.

Acta psychiatrica Scandinavica. Supplementum·2013
Same journal

Chronobiology of mood disorders.

Acta psychiatrica Scandinavica. Supplementum·2013
Same journal

It is time we managed depression: the emerging role of chronobiology. Preface.

Acta psychiatrica Scandinavica. Supplementum·2013
Same journal

Lifestyle management of unipolar depression.

Acta psychiatrica Scandinavica. Supplementum·2013
See all related articles

Remoxipride demonstrated no pharmacokinetic or pharmacodynamic interactions with biperiden, warfarin, diazepam, or ethanol in healthy volunteers. This suggests a low potential for drug interactions when remoxipride is co-administered with these common substances.

Area of Science:

  • Pharmacology
  • Clinical Pharmacology
  • Drug Interactions

Background:

  • Remoxipride is an atypical antipsychotic.
  • Understanding potential drug interactions is crucial for patient safety.
  • Co-administration of medications can alter pharmacokinetic and pharmacodynamic profiles.

Purpose of the Study:

  • To investigate the pharmacokinetic and pharmacodynamic interactions of remoxipride with biperiden, warfarin, diazepam, and ethanol.
  • To assess the safety and tolerability of remoxipride in combination with these agents.

Main Methods:

  • A randomized crossover study design was employed in 12 healthy volunteers.
  • Participants received single doses of remoxipride, the interacting drug, and the combination.
  • Pharmacokinetic parameters and pharmacodynamic effects (plasma prolactin, prothrombin time) were measured.

Related Experiment Videos

Main Results:

  • Remoxipride did not affect the pharmacokinetics of biperiden, warfarin enantiomers, diazepam, or ethanol.
  • Biperiden and ethanol did not alter remoxipride pharmacokinetics.
  • No significant pharmacokinetic or pharmacodynamic interactions were observed between remoxipride and the studied drugs.

Conclusions:

  • Remoxipride exhibits no significant pharmacokinetic or pharmacodynamic interactions with biperiden, warfarin, diazepam, or ethanol.
  • The findings suggest a favorable interaction profile for remoxipride, potentially simplifying co-administration regimens.